Golden Biotechnology Corporation Reports Earnings Results for the Half Year Ended June 30, 2022
August 11, 2022 at 11:17 pm EDT
Golden Biotechnology Corporation reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 60.93 million compared to TWD 36.2 million a year ago. Net loss was TWD 207.76 million compared to TWD 219.69 million a year ago. Basic loss per share from continuing operations was TWD 1.46 compared to TWD 1.66 a year ago.